{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T15:09:40Z","timestamp":1751728180933,"version":"3.37.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of squamous cell carcinomas of the head and neck (HNSCC) is consistently increasing, in association with human papillomavirus (HPV) infection, especially HPV16. HPV variants show heterogeneity in the pathogenicity of cervical cancer, but little has been established about their relevance on HNSCC. This review addresses the distribution of HPV16 variants in HNSCC and their potential contribution to clinical practice. A search was performed in PubMed using the keywords HNSCC HPV16 variants. Sixty articles were identified between 2000 and 2020 and 9 articles were selected for a systematic analysis. Clinical cohorts comprised 4 to 253 patients aged between 17 and 91\u00a0years with confirmed HPV16-positive HNSCC. Samples were collected from fresh biopsies of the tumour, oral rinse or formol fixed\/paraffin embedded tissue, from the oral cavity, oropharynx, hypopharynx, larynx and Waldeyer's tonsillar ring. HPV16 variants were identified using Sanger sequencing techniques. Seven studies addressed the HPV16 <jats:italic>E<\/jats:italic>6 gene, one studied <jats:italic>E<\/jats:italic>6 and <jats:italic>E<\/jats:italic>7, another studied <jats:italic>L<\/jats:italic>1 and one focused on the long control region. European variants represent 25\u201395%, Asian-American 5\u201357% and African 2\u20134% of the total isolates, suggesting a marked predominance of European strains. No correlations could be drawn with patient prognosis, partly because many studies relied on small patient cohorts. Additional studies are needed, particularly those employing next generation sequencing techniques (NGS), which will allow faster and accurate analysis of large numbers of samples.<\/jats:p>","DOI":"10.1186\/s12985-021-01688-9","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T12:02:59Z","timestamp":1636372979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities"],"prefix":"10.1186","volume":"18","author":[{"given":"Daniela","family":"Cochicho","sequence":"first","affiliation":[]},{"given":"Rui","family":"Gil da Costa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2653-2262","authenticated-orcid":false,"given":"Ana","family":"Felix","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"1688_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int. J. Cancer"},{"key":"1688_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3283380009","author":"R De Bree","year":"2010","unstructured":"De Bree R, Leemans CR. Recent advances in surgery for head and neck cancer. Curr Opin Oncol. 2010. https:\/\/doi.org\/10.1097\/CCO.0b013e3283380009.","journal-title":"Curr Opin Oncol"},{"key":"1688_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J. Clin"},{"key":"1688_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-019-0650-5","author":"JD McDermott","year":"2019","unstructured":"McDermott JD, Bowles DW. Epidemiology of head and neck squamous cell carcinomas: impact on staging and prevention strategies. Curr Treat Options Oncol. 2019. https:\/\/doi.org\/10.1007\/s11864-019-0650-5.","journal-title":"Curr Treat Options Oncol"},{"key":"1688_CR5","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2004.09.011","author":"ML Gillison","year":"2004","unstructured":"Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004. https:\/\/doi.org\/10.1053\/j.seminoncol.2004.09.011.","journal-title":"Semin Oncol"},{"key":"1688_CR6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.3870","author":"AK Chaturvedi","year":"2013","unstructured":"Chaturvedi AK, Anderson WF, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013. https:\/\/doi.org\/10.1200\/JCO.2013.50.3870.","journal-title":"J Clin Oncol"},{"key":"1688_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29330","author":"TZ Hwang","year":"2015","unstructured":"Hwang TZ, Hsiao JR, et al. Incidence trends of human papillomavirus related head and neck cancer in Taiwan. Int J Can. 2015. https:\/\/doi.org\/10.1002\/ijc.29330.","journal-title":"Int J Can"},{"key":"1688_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-010-9567-9","author":"J Mork","year":"2010","unstructured":"Mork J, Moller B, et al. Time trends in pharyngeal cancer incidence in Norway 1981\u20132005: a subsite analysis based on a re-abstraction and recoding of registered cases. Can Causes Control. 2010. https:\/\/doi.org\/10.1007\/s10552-010-9567-9.","journal-title":"Can Causes Control"},{"key":"1688_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.1804","author":"ZS Zumsteg","year":"2016","unstructured":"Zumsteg ZS, Cook-Wiens G, et al. Incidence of oropharyngeal cancer among elderly patients in the United States. JAMA Oncol. 2016. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1804.","journal-title":"JAMA Oncol"},{"key":"1688_CR10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00370","author":"JE Tota","year":"2019","unstructured":"Tota JE, Best AF, et al. Evolution of the oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals. J Clin Oncol. 2019. https:\/\/doi.org\/10.1200\/JCO.19.00370.","journal-title":"J Clin Oncol"},{"key":"1688_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.37","author":"F Faraji","year":"2017","unstructured":"Faraji F, Eisele DW, et al. Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma. Laryngoscope Investig Otolaryngol. 2017. https:\/\/doi.org\/10.1002\/lio2.37.","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"1688_CR12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.4596","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011. https:\/\/doi.org\/10.1200\/JCO.2011.36.4596.","journal-title":"J Clin Oncol"},{"key":"1688_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22177","author":"L Hammarstedt","year":"2006","unstructured":"Hammarstedt L, Lindquist D, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Can. 2006. https:\/\/doi.org\/10.1002\/ijc.22177.","journal-title":"Int J Can"},{"key":"1688_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606091","author":"JS Hocking","year":"2011","unstructured":"Hocking JS, Stein A, et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Can. 2011. https:\/\/doi.org\/10.1038\/sj.bjc.6606091.","journal-title":"Br J Can."},{"key":"1688_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn025","author":"ML Gillison","year":"2008","unstructured":"Gillison ML, D\u2019Souza G, et al. Distinct risk factor profiles for human papillomavirus type 6-positive and human papillomavirus type 6-negative head and neck cancers. J Natl Cancer Inst. 2008. https:\/\/doi.org\/10.1093\/jnci\/djn025.","journal-title":"J Natl Cancer Inst."},{"key":"1688_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12105-012-0363-6","volume":"6","author":"SK El-Mofty","year":"2012","unstructured":"El-Mofty SK. HPV-related squamous cell carcinoma variants in the head and neck. Head Neck Pathol. 2012;6:55. https:\/\/doi.org\/10.1007\/s12105-012-0363-6.","journal-title":"Head Neck Pathol."},{"unstructured":"WHO, World Health Organization. International agency for research on cancer (IARC) monographs on the evaluation of carcinogenic risks to humans. 2007;90(Human Papilloma Virus):689.\u00a0https:\/\/monographs.iarc.who.int\/wp-content\/uploads\/2018\/06\/mono90.pdf","key":"1688_CR17"},{"key":"1688_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.12.008","author":"H Polanska","year":"2014","unstructured":"Polanska H, Raudenska M, et al. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol. 2014. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.12.008.","journal-title":"Oral Oncol"},{"doi-asserted-by":"publisher","unstructured":"De Villiers EM, Fauquet C, et al. Classification of papillomaviruses. In: Virology. Academic Press. 2004; https:\/\/doi.org\/10.1016\/j.virol.2004.03.033","key":"1688_CR19","DOI":"10.1016\/j.virol.2004.03.033"},{"key":"1688_CR20","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.011478-0","author":"EM De Villiers","year":"2009","unstructured":"De Villiers EM, Gunst K. Characterization of seven novel human papillomavirus types isolated from cutaneous tissue, but also present in mucosal lesions. J Gen Virol. 2009. https:\/\/doi.org\/10.1099\/vir.0.011478-0.","journal-title":"J Gen Virol"},{"key":"1688_CR21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003. https:\/\/doi.org\/10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"key":"1688_CR22","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0551","author":"AR Kreimer","year":"2005","unstructured":"Kreimer AR, Clifford GM, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systemic review. Cancer Epidemiol Biomark Prev. 2005. https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0551.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1688_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.10.039","author":"A Huertas-Salgado","year":"2011","unstructured":"Huertas-Salgado A, Mart\u00edn-G\u00e1mez DC, et al. E6 molecular variants of human papillomavirus HPV type 16: an updated and unified criterion for clustering and nomenclature. Virology. 2011. https:\/\/doi.org\/10.1016\/j.virol.2010.10.039.","journal-title":"Virology"},{"key":"1688_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203403","author":"BA LeConte","year":"2018","unstructured":"LeConte BA, Szaniszlo P, et al. Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer. PLOS ONE. 2018. https:\/\/doi.org\/10.1371\/journal.pone.0203403.","journal-title":"PLOS ONE"},{"key":"1688_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.07.018.Human","author":"RD Burk","year":"2013","unstructured":"Burk RD, Harari A, et al. Human papillomavirus genome variants. Virology. 2013. https:\/\/doi.org\/10.1016\/j.virol.2013.07.018.Human.","journal-title":"Virology"},{"key":"1688_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw100","author":"L Mirabello","year":"2016","unstructured":"Mirabello L, Yeager M, et al. HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women. J Natl Cancer Inst. 2016. https:\/\/doi.org\/10.1093\/jnci\/djw100.","journal-title":"J Natl Cancer Inst"},{"key":"1688_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.06.011(8)","author":"L Sichero","year":"2012","unstructured":"Sichero L, Sim\u00e3o Sobrinho J, et al. Oncogenic potential diverge among human papillomavirus type 16 natural variants. Virology. 2012. https:\/\/doi.org\/10.1016\/j.virol.2012.06.011(8).","journal-title":"Virology"},{"key":"1688_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21655","author":"HU Bernard","year":"2006","unstructured":"Bernard HU, Calleja-Macias IE, et al. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006. https:\/\/doi.org\/10.1002\/ijc.21655.","journal-title":"Int J Cancer"},{"key":"1688_CR29","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1128\/jcm.29.9.1765-1772.1991","volume":"29","author":"L Ho","year":"1991","unstructured":"Ho L, Chan SY, et al. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol. 1991;29:1765\u201372. https:\/\/doi.org\/10.1128\/jcm.29.9.1765-1772.1991.","journal-title":"J. Clin. Microbiol."},{"key":"1688_CR30","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1128\/jvi.67.11.6413-6423.1993","volume":"67","author":"L Ho","year":"1993","unstructured":"Ho L, Chan SY, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol. 1993;67:6413\u201323. https:\/\/doi.org\/10.1128\/jvi.67.11.6413-6423.1993.","journal-title":"J. Virol."},{"key":"1688_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.4.803","author":"L Ho","year":"1993","unstructured":"Ho L, Tay SK, et al. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis. 1993. https:\/\/doi.org\/10.1093\/infdis\/168.4.803.","journal-title":"J Infect Dis"},{"key":"1688_CR32","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1128\/jvi.69.12.7743-7753.1995","volume":"69","author":"T Yamada","year":"1995","unstructured":"Yamada T, Wheeler CM, et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995;69:7743\u201353.","journal-title":"J Virol."},{"key":"1688_CR33","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1128\/jvi.71.3.2463-2472.1997","volume":"71","author":"T Yamada","year":"1997","unstructured":"Yamada T, Manos MM, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997;71:2463\u201372. https:\/\/doi.org\/10.1128\/jvi.71.3.2463-2472.1997.","journal-title":"J. Virol."},{"key":"1688_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-3379-6","author":"R Jackson","year":"2016","unstructured":"Jackson R, Rosa BA, et al. Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology. BMC Genomics. 2016. https:\/\/doi.org\/10.1186\/s12864-016-3379-6.","journal-title":"BMC Genomics"},{"key":"1688_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036239","author":"C Nordfors","year":"2012","unstructured":"Nordfors C, Sobkowiak M, et al. Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden. PLOS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0036239.","journal-title":"PLOS ONE"},{"key":"1688_CR36","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.10.6987-6993.1996","author":"MC St\u00f6ppler","year":"1996","unstructured":"St\u00f6ppler MC, Ching K, et al. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol. 1996. https:\/\/doi.org\/10.1128\/jvi.70.10.6987-6993.1996.","journal-title":"J Virol"},{"key":"1688_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","volume":"92","author":"ML Gillison","year":"2000","unstructured":"Gillison ML, Koch WM, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709\u201320. https:\/\/doi.org\/10.1093\/jnci\/92.9.709.","journal-title":"J. Natl. Cancer Inst."},{"key":"1688_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2003.10.011","author":"M Hoffmann","year":"2004","unstructured":"Hoffmann M, Lohrey C, et al. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas. Oral Oncol. 2004. https:\/\/doi.org\/10.1016\/j.oraloncology.2003.10.011.","journal-title":"Oral Oncol"},{"key":"1688_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.3.747(3)","author":"LF Xi","year":"1995","unstructured":"Xi LF, Demers GW, et al. Analysis of human papillomavirus type 16 variants indicates the establishment of persistent infection. J Infect Dis. 1995. https:\/\/doi.org\/10.1093\/infdis\/172.3.747(3).","journal-title":"J Infect Dis"},{"key":"1688_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.11.2957-2962.1995","author":"A Van Belkum","year":"1995","unstructured":"Van Belkum A, Juffermans L, et al. Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical neoplasia patients. J Clin Microbiol. 1995. https:\/\/doi.org\/10.1128\/jcm.33.11.2957-2962.1995.","journal-title":"J Clin Microbiol"},{"key":"1688_CR41","first-page":"8453","volume":"87","author":"L Zhang","year":"2015","unstructured":"Zhang L, Liao H, et al. Variants of human papillomavirus type 16 predispose toward persistent infection. Int J Clin Exp Pathol. 2015;87:8453.","journal-title":"Int J Clin Exp Pathol."},{"doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas Network Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; doi: https:\/\/doi.org\/10.1038\/nature14129","key":"1688_CR42","DOI":"10.1038\/nature14129"},{"key":"1688_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv403","author":"X Castellsagu\u00e9","year":"2016","unstructured":"Castellsagu\u00e9 X, Alemany L, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016. https:\/\/doi.org\/10.1093\/jnci\/djv403.","journal-title":"J Natl Cancer Inst"},{"key":"1688_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8040041","author":"R Dok","year":"2016","unstructured":"Dok R, Nuyts S. HPV positive head and neck cancers: Molecular pathogenesis and evolving treatment strategies. Cancers (Basel). 2016. https:\/\/doi.org\/10.3390\/cancers8040041.","journal-title":"Cancers (Basel)"},{"key":"1688_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-020-00391-1","author":"F Pakdel","year":"2020","unstructured":"Pakdel F, Farhadi A, et al. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16INK4a and NF-\u03baB expression in head and neck squamous cell carcinomas in Southwestern Iran. J Microbiol. 2020. https:\/\/doi.org\/10.1007\/s42770-020-00391-1.","journal-title":"J Microbiol"},{"key":"1688_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2015.05.004","author":"M Cullen","year":"2015","unstructured":"Cullen M, Boland JF, et al. Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Res. 2015. https:\/\/doi.org\/10.1016\/j.pvr.2015.05.004.","journal-title":"Papillomavirus Res"},{"key":"1688_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/v8030079","author":"E Lavezzo","year":"2016","unstructured":"Lavezzo E, Masi G, et al. Characterization of intra-type variants of oncogenic human papillomaviruses by next-generation deep sequencing of the E6\/E7 region. Viruses. 2016. https:\/\/doi.org\/10.3390\/v8030079.","journal-title":"Viruses"},{"key":"1688_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00844-17","author":"P van der Weele","year":"2017","unstructured":"van der Weele P, Meijer CJLM, et al. Whole-Genome Sequencing and Variant Analysis of Hpv16 Infections. J Virol. 2017. https:\/\/doi.org\/10.1128\/JVI.00844-17.","journal-title":"J Virol"},{"doi-asserted-by":"crossref","unstructured":"Badaracco G, Rizzo C, et al. Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncol Rep. 2007","key":"1688_CR49","DOI":"10.3892\/or.17.4.931"},{"key":"1688_CR50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0498.Oral","author":"Y Agrawal","year":"2008","unstructured":"Agrawal Y, Koch WM, et al. Oral HPV infection before and after treatment for HPV16-positive and negative head and neck squamous cell carcinoma. Oral Oncol. 2008. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0498.Oral.","journal-title":"Oral Oncol"},{"key":"1688_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-008-0490-3","author":"P Boscolo-Rizzo","year":"2009","unstructured":"Boscolo-Rizzo P, Da Mosto MC, et al. HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J Cancer Res Clin Oncol. 2009. https:\/\/doi.org\/10.1007\/s00432-008-0490-3.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1688_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2012.09.009","author":"AW Joseph","year":"2013","unstructured":"Joseph AW, Ogawa T, et al. Molecular etiology of second primary tumours in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas. Oral Oncol. 2013. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.09.009.","journal-title":"Oral Oncol"},{"unstructured":"Hassani S, Castillo A, Ohori J-I, Higashi M, Kurono Y, Akiba S, Koriyama C, Molecular pathogenesis of human papillomavirus type 16 in Tonsillar squamous cell carcinoma. Anticancer Res. 2015","key":"1688_CR53"},{"key":"1688_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-016-0067-8","author":"JC Betiol","year":"2016","unstructured":"Betiol JC, de Matos LL, et al. Prevalence of human papillomavirus types and variants and p16INK4a expression in head and neck squamous cells carcinomas in S\u00e3o Paulo, Brazil. Infectious Agents Cancer. 2016. https:\/\/doi.org\/10.1186\/s13027-016-0067-8.","journal-title":"Infectious Agents Cancer"},{"key":"1688_CR55","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0912217","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010. https:\/\/doi.org\/10.1056\/nejmoa0912217.","journal-title":"N Engl J Med"},{"key":"1688_CR56","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djz224","volume":"112","author":"BT Beaty","year":"2019","unstructured":"Beaty BT, Moon DH, et al. PIK3CA mutation in HPV-associated OPSCC patients receiving deintensified chemoradiation. JNCI J Natl Cancer Inst. 2019;112:855\u20138. https:\/\/doi.org\/10.1093\/jnci\/djz224.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1688_CR57","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-12-2959","author":"LL Villa","year":"2000","unstructured":"Villa LL, Sichero L, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol. 2000. https:\/\/doi.org\/10.1099\/0022-1317-81-12-2959.","journal-title":"J Gen Virol"},{"key":"1688_CR58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4179.A","author":"M Schiffman","year":"2010","unstructured":"Schiffman M, Rodriguez AC, et al. A population-based prospective study of carcinogenic human papillomavirus (HPV) variant lineages, viral persistence, and cervical neoplasia. NIH Public Access. 2010. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4179.A.","journal-title":"NIH Public Access"},{"key":"1688_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22481","author":"L Sichero","year":"2007","unstructured":"Sichero L, Ferreira S, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007. https:\/\/doi.org\/10.1002\/ijc.22481.","journal-title":"Int J Cancer"},{"key":"1688_CR60","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00017-18","author":"Y Hirose","year":"2018","unstructured":"Hirose Y, Onuki M, et al. Within-host variations of human papillomavirus reveal APOBEC signature mutagenesis in the viral genome. J Virol. 2018. https:\/\/doi.org\/10.1128\/jvi.00017-18.","journal-title":"J Virol"},{"key":"1688_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/v10020080","author":"L Mirabello","year":"2018","unstructured":"Mirabello L, Clarke MA, et al. The intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcinogenesis. Viruses. 2018. https:\/\/doi.org\/10.3390\/v10020080.","journal-title":"Viruses"},{"key":"1688_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14730-1","author":"B Zhu","year":"2020","unstructured":"Zhu B, Xiao Y, et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-14730-1.","journal-title":"Nat Commun"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-021-01688-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T12:11:17Z","timestamp":1636373477000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-021-01688-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1688"],"URL":"https:\/\/doi.org\/10.1186\/s12985-021-01688-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}